Karl Rothweiler
Founding Investor, Member of the Supervisory Board
Aglaia Oncology FundsDe Bilt, Utrecht, The Netherlands
14 investmentsKarl Rothweiler is a Founding Investor, Member of the Supervisory Board at Aglaia Oncology Funds based in De Bilt, Utrecht, The Netherlands. Karl Rothweiler has backed 14 companies, including Cristal Therapeutics, Macrophage Pharma and InteRNA Technologies. Investment focus areas include Health Care, Information Technology (IT) and Biotech.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (6)
Showing 1–6 of 6
Access Full Contact Information
Get Karl Rothweiler's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.